Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...

It was a busy week in the biotech sector, marked by significant regulatory and pipeline updates. Among these, shares of ...

Takeda boosts profit margins with AI-driven growth, FY2024 guidance upgrade, share buyback plan & promising drug launches.

Each Monday, the Tenable Exposure Management Academy provides the practical, real-world guidance you need to shift from vulnerability management to exposure management. In this blog, we share three ...

Zero Networks, a leader in zero trust security solutions, is proud to announce it has received a 5-Star Award in the 2025 CRN Partner Program Guide. This elite recognition is given to select companies ...

CyberArk Software (NASDAQ:CYBR – Get Free Report) had its price target reduced by equities research analysts at Truist ...

Corebridge Financial Inc. lessened its stake in shares of CyberArk Software Ltd. (NASDAQ:CYBR – Free Report) by 3.1% during ...

The ASX health sector retreats again with Morgans analyst Scott Power noting various factors putting pressure on the sector ...

INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage inflammation and immunology company focused on developing treatments that harness ...

On January 7th, 2025, the Cybernews research team discovered a major security oversight compromising the “Gay Daddy: 40+ Date & Chat” app on the App Store. It is one of thousands of iOS apps leaking ...